Skip to main content
Fig. 26 | Malaria Journal

Fig. 26

From: Systematic identification of plausible pathways to potential harm via problem formulation for investigational releases of a population suppression gene drive to control the human malaria vector Anopheles gambiae in West Africa

Fig. 26

Pathway 24 Human health: Potentially altered physiology in dsxFCRISPRh transgenic could lead them to vector human disease not previously vectored by Anopheles gambiae. Relevant physiology in this pathway might include immune system function or capacity for co-infection. Diseases newly transmitted by transgenics would necessarily already be present in the environment into which the transgenics were released. The components of vectorial capacity (V) that would be affected in this pathway are shown in red in the equation

Back to article page
\